Skip to main content

Table 1 IHC scoring for LIMK1 expression and nuclear localization

From: Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression

LIMK1 staining by IHC

Normal

(67 samples)

Breast Cancer

(84 samples)

Strong Cytoplasmic*

48%

76%

Nuclear staining in those with strong cytoplasmic LIMK1+

27% (13%)

52% (39%)

  1. *Percent of total
  2. + Percent of subset with strong cytoplasmic staining; (% of total)
Back to article page

Molecular Cancer

ISSN: 1476-4598